Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | CRNX | PTCT | ||
| Company | Turning Point Therapeutics Inc | Crinetics Pharmaceuticals Inc | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 56.00 | 42.09 | ||
| High | 76.01 | 58.03 | 43.41 | ||
| Low | 75.98 | 55.31 | 41.21 | ||
| Last | 76.01 | 57.03 | 42.89 | ||
| Change | +0.52 | +0.96 | +0.93 | ||
| % Change | +0.69% | +1.71% | +2.22% | ||
| Volume | 2,843,300 | 681,300 | 599,100 | ||
| 20-Day Average Volume | 962,475 | 637,345 | 709,490 | ||
| Previous Close | 75.49 | 56.07 | 41.96 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 57.41 | 41.75 | ||
| 20-Day Raw Stochastic | 100.00% | 43.21% | 53.10% | ||
| 20-Day Relative Strength | 74.20% | 52.09% | 57.18% | ||
| Weighted Alpha | -18.70 | +61.51 | +93.00 | ||
| Today's Opinion | 96% Buy | 80% Buy | 96% Buy | ||
| Previous Opinion | 96% Buy | 80% Buy | 96% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | -4.41% since 11/14/24 | +1.20% since 11/14/24 | ||
| Low | 74.86 on 08/10/22 | 52.85 on 11/18/24 | 38.26 on 11/20/24 | ||
| High | 76.01 on 08/16/22 | 60.15 on 11/15/24 | 43.41 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | -2.84% since 10/21/24 | +11.58% since 10/21/24 | ||
| Low | 74.57 on 07/21/22 | 52.85 on 11/18/24 | 38.18 on 10/23/24 | ||
| High | 76.01 on 08/16/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | +5.69% since 08/21/24 | +26.41% since 08/21/24 | ||
| Low | 30.85 on 05/25/22 | 49.13 on 09/24/24 | 30.41 on 09/05/24 | ||
| High | 76.01 on 08/16/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +15.21% since 05/21/24 | +10.40% since 05/21/24 | ||
| Low | 23.77 on 03/15/22 | 41.01 on 06/26/24 | 28.72 on 06/28/24 | ||
| High | 76.01 on 08/16/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 5,199,819 | 3,236,165 | ||
| Shares Outstanding, K | 50,074 | 92,738 | 77,125 | ||
| Annual Sales | 30,830,000 | 4,010,000 | 937,820,000 | ||
| Annual Net Income | -236,550,000 | -214,530,000 | -626,600,000 | ||
| Last Quarter Sales | 120,000 | 400,000 | 196,790,000 | ||
| Last Quarter Net Income | -123,090,000 | -74,050,000 | -106,650,000 | ||
| 60-Month Beta | -0.18 | 0.62 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -0.96 on 11/12/24 | -1.39 on 11/07/24 | ||
| Latest Earnings Date | 08/08/22 | 11/12/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||